Growth Metrics

Biolife Solutions (BLFS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$2.6 million.

  • Biolife Solutions' Cash from Financing Activities fell 14572.53% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.5 million, marking a year-over-year decrease of 27516.8%. This contributed to the annual value of -$6.8 million for FY2024, which is 16404.49% down from last year.
  • Per Biolife Solutions' latest filing, its Cash from Financing Activities stood at -$2.6 million for Q3 2025, which was down 14572.53% from -$2.9 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Cash from Financing Activities ranged from a high of $17.4 million in Q3 2022 and a low of -$4.1 million during Q4 2024
  • Over the past 5 years, Biolife Solutions' median Cash from Financing Activities value was -$704000.0 (recorded in 2024), while the average stood at $469368.4.
  • In the last 5 years, Biolife Solutions' Cash from Financing Activities skyrocketed by 174565.22% in 2022 and then crashed by 30880.68% in 2025.
  • Over the past 5 years, Biolife Solutions' Cash from Financing Activities (Quarter) stood at -$2.1 million in 2021, then surged by 70.31% to -$625000.0 in 2022, then skyrocketed by 1674.56% to $9.8 million in 2023, then tumbled by 141.52% to -$4.1 million in 2024, then skyrocketed by 37.4% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$2.9 million for Q2 2025, and -$3.0 million during Q1 2025.